Gilead Announces U.S. FDA Priority Review Designation for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for Treatment of HIV
FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug. 10, 2017-- Gilead Sciences, Inc. (Nasdaq: GILD) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company ’s New Drug Application (NDA) for an... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 10, 2017 Category: Drugs & Pharmacology Source Type: news
Mylan launches new HIV treatment in India
Mylan NV said it is the first company to offer an innovative, reduced-dose HIV treatment in India.
Mylan (Nasdaq:MYL) subsidiary Mylan Pharmaceuticals Private Limited has received marketing authorization from the Drug Controller General of India for its antiretroviral drug Avonza. The fixed-dose combination comprised of Efavirenz, Lamivudine and Tenofovir Disoproxil Fumarate Tablets is recommen ded by the World Health Organization as an alternative first-line regimen for people being treated for… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 9, 2017 Category: Pharmaceuticals Authors: Patty Tascarella Source Type: news
Lower Risk of Adverse Birth Outcomes With Tenofovir-emtricitabine-efavirenz Lower Risk of Adverse Birth Outcomes With Tenofovir-emtricitabine-efavirenz
Exposure of infants, from conception, to the antiretroviral combination of tenofovir disoproxil fumarate, emtricitabine, and efavirenz (TFC-FTC-EFV) is associated with a lower risk of adverse birth outcomes, compared with exposure to other antiretroviral regimens, according to data from Botswana.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 8, 2017 Category: Consumer Health News Tags: Medscape Today News Source Type: news
Bone Risk with Tenofovir: How to Handle? (CME/CE)
(MedPage Today) -- Studies examine role of common HIV drug (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 28, 2017 Category: Primary Care Source Type: news
Janssen Receives Positive CHMP Opinion for SYMTUZA ™
The First Darunavir-Based Single-Tablet Regimen for the Treatment of HIV
- Proven efficacy and durability of darunavir combined with the improved renal laboratory and bone mineral density profile of emtricitabine/tenofovir alafenamide as compared to emtricitabine/tenofovir disoproxil fumarate into one single tablet (Source: Johnson and Johnson)
Source: Johnson and Johnson - July 21, 2017 Category: Pharmaceuticals Source Type: news
Tenofovir to Prevent Mother-to-child Transmission of HBV Tenofovir to Prevent Mother-to-child Transmission of HBV
Is tenofovir safe and tolerable for both the mother and fetus when administered to pregnant women with chronic HBV infection?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 20, 2017 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news
How Common Are STIs?
Discussion
Of the 30 different microbes which can be transmitted by sexual contact, 8 have the greatest incidence of transmitting disease. Four are curable (Chlamydia, Gonorrhea, Syphilis and Trichomoniasis) and 4 are incurable at present (Hepatitis B, Herpes simplex virus (HSV), Human immunodeficiency virus (HIV) and Human papillomavirus (HPV)).
Sexually transmitted infections (STIs) are important as they can cause:
Increased rates of acquisition of other STIs (ie HSV and syphilis increase the rate of HIV infection acquisition)
Pelvic inflammatory disease and infertility
Stillbirth and neonatal death
Neonatal morbidity i...
Source: PediatricEducation.org - July 17, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news
HCC Drops Beyond Five Years of Entecavir/Tenofovir Tx for Hep B
Older age, lower platelets at baseline and year five, liver stiffness ≥ 12 kPa linked to HCC development (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - June 21, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Infections, Oncology, Pharmacy, Journal, Source Type: news
Efficacy and Safety After Switching From TDF to TAF in HIV Efficacy and Safety After Switching From TDF to TAF in HIV
What benefits might tenofovir alafenamide offer virologically suppressed HIV patients over tenofovir disoproxil fumarate?JAIDS: Journal of Acquired Immune Deficiency Syndromes (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 12, 2017 Category: Consumer Health News Tags: HIV/AIDS Journal Article Source Type: news
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Fixed-Dose Combination of Bictegravir, Emtricitabine and Tenofovir Alafenamide for HIV Treatment
FOSTER CITY, Calif.--(BUSINESS WIRE)--Jun. 12, 2017-- Gilead Sciences, Inc. (NASDAQ: GILD) today announced that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for an investigational, once-daily single... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 12, 2017 Category: Drugs & Pharmacology Source Type: news
FDA Approves First Generic Truvada in US FDA Approves First Generic Truvada in US
Generic versions of emtricitabine/tenofovir disoproxil, which can both treat and prevent HIV infections, are already available in other countries.FDA Approvals (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 9, 2017 Category: Consumer Health News Tags: HIV/AIDS News Alert Source Type: news
Health Highlights: June 9, 2017
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay:
Generic Version of HIV Drug Truvada Approved by FDA
The first generic version of the HIV drug Truvada (emtricitabine and tenofovir disoproxil... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 9, 2017 Category: General Medicine Source Type: news
Vaginal bacteria modify HIV tenofovir microbicide efficacy in African women
This study provides evidence linking vaginal bacteria to microbicide efficacy through tenofovir depletion via bacterial metabolism. (Source: ScienceNOW)
Source: ScienceNOW - June 1, 2017 Category: Science Authors: Klatt, N. R., Cheu, R., Birse, K., Zevin, A. S., Perner, M., Noël-Romas, L., Grobler, A., Westmacott, G., Xie, I. Y., Butler, J., Mansoor, L., McKinnon, L. R., Passmore, J.-A. S., Abdool Karim, Q., Abdool Karim, S. S., Burgener, A. D. Tags: Medicine, Diseases r-articles Source Type: news
Gilead reports positive data from four Phase III combination trials for HIV-1
US-based biopharmaceutical firm Gilead Sciences has reported positive results from four Phase III clinical trials investigating the combination of bictegravir (BIC), emtricitabine (FTC) and tenofovir alafenamide (TAF) to treat patients with HIV-1. (Source: Drug Development Technology)
Source: Drug Development Technology - May 30, 2017 Category: Pharmaceuticals Source Type: news
Truvada (Emtricitabine and Tenofovir Disoproxil Fumarate) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - May 8, 2017 Category: Drugs & Pharmacology Source Type: news
